Literature DB >> 2008831

Effect of direct intracoronary administration of methylergonovine in patients with and without variant angina.

Y Igarashi1, M Yamazoe, A Shibata.   

Abstract

The effects of intracoronary administration of methylergonovine were studied in 21 patients with variant angina and 22 patients with atypical chest pain and in others without angina pectoris (control group). Methylergonovine was administered continuously at a rate of 10 micrograms/min up to 50 micrograms. In all patients with variant angina, coronary spasm was provoked at a mean dose of 28 +/- 13 micrograms (mean +/- SD). In the control group neither ischemic ST change nor localized spasm occurred. The basal tone of the right coronary artery was significantly lower than that of the left coronary artery. The percentage of vasoconstriction of the right coronary artery was significantly higher than that of the left coronary artery. These results suggest that spasm provocation tests, which use an intracoronary injection of a relatively low dose of methylergonovine, have a high sensitivity in variant angina and the vasoreactivity of the right coronary artery may be greater than that of the other coronary arteries.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2008831     DOI: 10.1016/0002-8703(91)90667-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  2 in total

1.  Current advances in the understanding of coronary vasospasm.

Authors:  Ming-Jui Hung
Journal:  World J Cardiol       Date:  2010-02-26

2.  An increased monocyte count predicts coronary artery spasm in patients with resting chest pain and insignificant coronary artery stenosis.

Authors:  Kyeong Ho Yun; Seok Kyu Oh; Eun Mi Park; Hyun Jung Kim; Sung Hee Shin; Eun Mi Lee; Sang Jae Rhee; Nam Jin Yoo; Nam-Ho Kim; Jin-Won Jeong; Myung Ho Jeong
Journal:  Korean J Intern Med       Date:  2006-06       Impact factor: 2.884

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.